Crossmark

Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer

Crossref DOI link: https://doi.org/10.1186/s13014-018-1165-0

Published Online: 2018-11-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stefanowicz, Sarah

Stützer, Kristin

Zschaeck, Sebastian

Jakobi, Annika

Troost, Esther G. C. http://orcid.org/0000-0001-9550-9050
License Information

Text and Data Mining valid from 2018-11-22
More Information

Article History

Received: 24 July 2018

Accepted: 30 October 2018

First Online: 22 November 2018

Ethics approval and consent to participate

: The study was approved by the ethics committees of the University Hospital Dresden (EK 98032017) and of the Charité Universitätsmedizin Berlin (EA1/236/16).

: Patients treated at the Charité Universitätsmedizin Berlin consented in writing for the use of their anonymous data for research.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.